Search Results - "WHITWORTH, Amy"

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients by Ma, Wen Wee, Xie, Hao, Fetterly, Gerald, Pitzonka, Laura, Whitworth, Amy, LeVea, Charles, Wilton, John, Mantione, Krystin, Schihl, Sarah, Dy, Grace K, Boland, Patrick, Iyer, Renuka, Tan, Wei, Brady, William, Straubinger, Robert M, Adjei, Alex A

“…Preclinical studies demonstrated antitumor activity of dovitinib in pancreatic cancer models. This phase Ib study aimed to determine the maximum tolerated dose…”
Get full text

Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer by WEN WEE MA, MESSERSMITH, Wells A, JIMENO, Antonio, DY, Grace K, WEEKES, Colin D, WHITWORTH, Amy, REN, Chen, MANIAR, Manoj, WILHELM, Francois, ECKHARDT, S. Gail, ADJEI, Alex A

“…Rigosertib, a dual non-ATP inhibitor of polo-like kinase 1 (Plk1) and phosphoinositide 3-kinase pathways (PI3K), and gemcitabine have synergistic antitumor…”
Get full text

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics by Sher, Taimur, Miller, Kena C., Lawrence, David, Whitworth, Amy, Hernandez-Ilizaliturri, Francisco, Czuczman, Myron S., Miller, Austin, Lawrence, William, Bilgrami, Syed Ali, Sood, Raman, Wood, Margaret T., Block, Annemarie W., Lee, Kelvin, Chanan-Khan, Asher Alban

“…Patients with chronic lymphocytic lymphoma (CLL) with high-risk cytogenetics [del(11q)(q22.3) or del(17p)(p13.1)] have limited therapeutic options and their…”
Get full text

Evaluation of Quality-of-life (QoL) in patients(pts) with advanced solid tumors as screening tool during phase 1 clinical trial recruitment- risk assessment for adverse events and subject replacement by Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M, Ma, Wen Wee, Miller, Austin, Adjei, Alex A., Dy, Grace K.

“…Abstract only…”
Get full text

A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors by Fetterly, Gerald J., Pitzonka, Laura, Zhao, Yujie, Dy, Grace K., Iyer, Renuka V., Taubes, Susan, Perez, Jose Ricardo, Culver, Kenneth W., Wilton, John, Mongiardo, Krystin, Tan, Wei, Brady, William E., Whitworth, Amy, Adjei, Alex A., Ma, Wen Wee

“…Abstract only…”
Get full text

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events by Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M, Ma, Wen Wee, Miller, Austin, Adjei, Alex A, Dy, Grace K

“…: Serious adverse events (SAEs) and subject replacements occur frequently in phase 1 oncology clinical trials. Whether baseline quality-of-life (QOL) or social…”
Get full text

Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia by Chanan-Khan, Asher A, Whitworth, Amy, Bangia, Naveen, Porter, Carl W, Lee, Kelvin

Get full text

Management of patients with chronic lymphocytic leukemia treated with lenalidomide by Miller, Kena C, Musial, Laurie, Whitworth, Amy, Chanan-Khan, Asher

“…Lenalidomide is an immunomodulatory drug that has shown preliminary activity in the treatment of chronic lymphocytic leukemia (CLL). Much is known about the…”
Get full text

Management of patients with chronic lymphocytic leukemia treated with lenalidomide by Miller, Kena C, Musial, Laurie, Whitworth, Amy, Chanan-Khan, Asher

“…Lenalidomide is an immunomodulatory drug that has shown preliminary activity in the treatment of chronic lymphocytic leukemia (CLL). Much is known about the…”
Get full text

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT) for the Treatment of Previously Untreated Multiple Myeloma by Chanan-Khan, Asher A., Miller, Kena C., DePaolo, Dawn, Padmanabhan, Swaminathan, Whitworth, Amy, Ailawadhi, Sikander, Lee, Kelvin, Czuczman, Myron S.

“…Introduction: Orlowski et al were the first to report that addition of PLD resulted in enhanced efficacy of bortezomib. To further optimize the clinical…”
Get full text

Book Review: The Perspective of Morality: Philosophical Foundations of Thomistic Virtue Ethics by Whitworth, Amy F.

“…The Perspective of Morality: Philosophical Foundations of Thomistic Virtue Ethics. By Rhonheimer, Martin. Translated by Malsbary, Gerald. Washington: Catholic…”
Get full text

The Perspective of Morality: Philosophical Foundations of Thomistic Virtue Ethics by Whitworth, Amy F

“…[...] morality is "the empowering of rationality with respect to concrete actions" (17). Because the human being as acting subject constantly strives toward…”
Get full text

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia by Sher, Taimur, Patel, Mehul, Whitworth, Amy, Miller, Kena, Musial, Laurie, Lawrence, David, Padmanabhan, Swaminathan, Ailawadhi, Sikander, Wilding, Gregory, DePaolo, Dawn, Bangia, Naveen, Czuczman, Myron S., Wallace, Paul K., Lee, Kelvin P., Khan, Asher Chanan

“…INTRODUCTION: We have previously reported that in patients with B-CLL, lenalidomide induces a tumor flare reaction (TFR) that is clinically characterized by…”
Get full text

Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma by DePaolo, Dawn, Miller, Kena C., Whitworth, Amy, Mohr, Alice, Mashtare, Terry L., Wilding, Gregory, Ailawadhi, Sikander, Padmanabhan, Swaminathan, Chanan-Khan, Asher A.

“…Introduction: Bortezomib, a proteasome inhibitor is an effective antimyeloma therapy. We recently reported that multiple myeloma patients treated with…”
Get full text

Attending to presence: A study of John Duns Scotus' account of sense cognition by Whitworth, Amy F

“…This project is guided and motivated by the question concerning the nature of the phantasm as that which mediates between sensation and intellection in John…”
Get full text

Attending to presence: A study of John Duns Scotus' account of sense cognition by Whitworth, Amy F

“…This project is guided and motivated by the question concerning the nature of the phantasm as that which mediates between sensation and intellection in John…”
Get full text